| Drug Name | ( Arava (LEFLUNOMIDE |
|---|---|
| Drug Class |
Immunosuppressant
|
| Risk minimization type |
Direct Healthcare Professional Communication DHPC
|
| Specialty (Theraputic area) |
Rheumatology
|
| Risk |
Risk of hepatotoxicity Risk of serious birth defects |
| Dear Healthcare provider letter DHPC |
|